A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
Clinical trial NCT06097273 · COMPLETED
Trial details
- NCT number
- NCT06097273
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-19
- Primary completion
- 2024-05-28
- Enrollment
- 8061
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.